| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| cd47 antibody drug | 0.79 | 0.1 | 8638 | 8 | 18 |
| cd47 | 1.78 | 0.5 | 5165 | 78 | 4 |
| antibody | 1.03 | 0.9 | 7070 | 3 | 8 |
| drug | 1.62 | 0.7 | 9080 | 13 | 4 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| cd47 antibody drug | 0.11 | 0.8 | 7310 | 91 |
| cd47 antibody side effect | 0.33 | 0.5 | 9917 | 15 |
| anti cd47 antibody drug | 1.03 | 0.4 | 5492 | 90 |
| anti-cd47 antibody | 0.47 | 0.1 | 5995 | 82 |
| anti cd47 antibody clinical trial | 0.22 | 0.7 | 7870 | 94 |
| cd47 antibody clinical trial | 1.51 | 0.5 | 1615 | 100 |
| anti mouse cd47 antibody | 0.05 | 0.7 | 2576 | 15 |
| anti-cd24 antibody side effects | 0.43 | 0.9 | 2407 | 72 |
| anti cd47 antibody magrolimab | 1.62 | 0.9 | 7939 | 79 |
| anti-cd47 | 0.89 | 0.9 | 5323 | 6 |
| cd38 antibodies side effects | 0.13 | 0.2 | 3702 | 31 |
| cd47 red blood cell | 1.18 | 1 | 7802 | 57 |
| role of cd47 in hematological malignancies | 0.53 | 0.9 | 6517 | 93 |
| anti-cd47 mab | 0.24 | 0.2 | 7001 | 26 |
| anti-cd88 antibody side effects | 0.63 | 1 | 4506 | 17 |
| leukocyte surface antigen cd47 | 0.02 | 0.4 | 3103 | 20 |
| anti-mouse cd47 | 1.52 | 0.1 | 4826 | 52 |
| anti cd47 blood bank interference | 1.65 | 0.2 | 1440 | 7 |
| cd47 signals t cell death | 1.2 | 0.3 | 9480 | 70 |
| binding mechanism of cd47 | 1.85 | 0.4 | 8109 | 99 |
| cd47/cd20 | 1.36 | 0.9 | 2760 | 68 |
